HomeBiotech

Biotech

ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer

ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer

December 14, 2020

Ascendis Pharma A/S Announces Planned Board Transition

Ascendis Pharma A/S Announces Planned Board Transition

December 14, 2020

Champions Oncology Reports Record Quarterly Revenue of $10.1 Million

Champions Oncology Reports Record Quarterly Revenue of $10.1 Million

December 14, 2020

Implied Volatility Surging for Arbutus Biopharma (ABUS) Stock Options

Implied Volatility Surging for Arbutus Biopharma (ABUS) Stock Options

December 14, 2020

Implied Volatility Surging for Cardiff Oncology (CRDF) Stock Options

Implied Volatility Surging for Cardiff Oncology (CRDF) Stock Options

December 14, 2020

KalVista Pharmaceuticals (KALV) Catches Eye: Stock Jumps 7.4%

KalVista Pharmaceuticals (KALV) Catches Eye: Stock Jumps 7.4%

December 14, 2020

New Strong Sell Stocks for December 14th

New Strong Sell Stocks for December 14th

December 14, 2020

Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020

Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020

December 14, 2020

Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update

Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update

December 14, 2020

Curis Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Curis Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

December 14, 2020

« 1 … 681 682 683 684 685 … 690 »